{"company":{"id":3783553,"name":"Climb Bio","domain":"climbbio.com","url":"https://alion.io/company/climbbio"},"section":"news","answer":"Climb Bio: 9 headlines on record, 2 headlines in the last 90 days. Its story counts 9 milestones.","figures":[{"label":"Headlines","value":"9"},{"label":"In 90 days","value":"2"},{"label":"Milestones","value":"9"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":8},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":9}],"news":[{"date":"2026-09-03","kind":"News","title":"Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy","source":"markets.businessinsider.com","url":"https://markets.businessinsider.com/news/stocks/climb-bio-announces-clym116-phase-1-data-demonstrating-prolonged-half-life-and-best-in-class-april-suppression-supporting-every-12-week-dosing-in-iga-nephropathy-1036519024"},{"date":"2026-08-06","kind":"Press release","title":"Climb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates","source":"Nasdaq","url":"https://nasdaq.com/press-release/climb-bio-reports-second-quarter-2026-financial-results-and-provides-business-updates"},{"date":"2026-05-07","kind":"Press release","title":"Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates","source":"The Manila Times","url":"https://manilatimes.net/2026/05/07/tmt-newswire/globenewswire/climb-bio-reports-first-quarter-2026-financial-results-and-provides-business-updates/2338247"},{"date":"2026-04-08","kind":"News","title":"Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026","source":"taiwannews.com.tw","url":"https://taiwannews.com.tw/news/6336677"},{"date":"2025-03-25","kind":"Press release","title":"Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates","source":"streetinsider.com","url":"https://streetinsider.com/Globe+Newswire/Climb+Bio+Reports+Fourth+Quarter+and+Year-End+2024+Financial+Results+and+Provides+Business+Updates/24546154.html"},{"date":"2025-01-08","kind":"News","title":"Climb Bio, Inc. Expands B-cell Targeted Therapeutics Pipeline with Exclusive License for CLYM116, an Anti-APRIL Monoclonal Antibody","source":"Nasdaq","url":"https://nasdaq.com/articles/climb-bio-inc-expands-b-cell-targeted-therapeutics-pipeline-exclusive-license-clym116-anti"},{"date":"2024-12-19","kind":"News","title":"Climb Bio to be Added to the Nasdaq Biotechnology Index","source":"YahooFinance","url":"https://finance.yahoo.com/news/climb-bio-added-nasdaq-biotechnology-120000270.html"},{"date":"2024-09-11","kind":"Blog","title":"Hello world!","url":"https://climbbio.com/hello-world/"}],"story":[{"title":"Went public NASDAQ: CLYM"},{"title":"Raised a round Venture round $110.1M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1768446/000176844626000001/"},{"title":"Raised a round Venture round $120M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1768446/000176844624000002/"},{"title":"Raised a round Venture round $41.9M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1768446/000176844624000001/"},{"title":"Raised a round Venture round $60M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1768446/000176844621000001/"},{"title":"Raised a round Venture round $5M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1768446/000176844620000003/"},{"title":"Raised a round Venture round $10M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1768446/000176844619000003/"},{"title":"Raised a round Venture round $16.3M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1768446/000156761919004873/"},{"title":"Founded"}],"as_of":"2026-11-17","cite":"Climb Bio, News. Alion, Nov 17, 2026. https://alion.io/company/climbbio/news","html_url":"https://alion.io/company/climbbio/news","json_url":"https://alion.io/company/climbbio/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T21:12:28Z"}}